Why did Corteva's stock drop nearly 12% despite beating earnings and raising its full-year outlook?

Corteva's stock dropped nearly 12% primarily due to a revenue miss in its second quarter, particularly in the Crop Protection segment, even though the company beat earnings and raised its full-year outlook; market anxiety about the upcoming separation into New Corteva and Vylor also contributed, although management significantly reduced the estimated separation dissynergies.

What key factor will determine whether Corteva's raised guidance and investor confidence are validated?

The performance of Corteva's third quarter—especially regarding crop protection pricing—will be crucial in validating the raised guidance and restoring investor confidence.

Corteva Raised Guidance and Still Dropped 12%. Is the Selloff Overdone?

Aug 2, 2026

Corteva Inc. stock fell 12% despite raising full-year guidance, driven by a Crop Protection revenue miss and separation concerns. Analysts suggest potential upside pending validation from third-quarter crop protection pricing.